METHYL (4R)-8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE
UNII PV3ALL6HPF
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl (4r)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PV3ALL6HPF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 917389-34-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H30F4N4O4 DDWYVVLPVLTZIN-XMMPIXPASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl (4r)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.